Develops oncolytic viral immunotherapies for cancer patients.
Dec 2025Revenue $8.00K/yrExpenses $33.2M/yr
No trendCash runway ≈ 8 months from Jun 2026
Figures by year
When will GENELUX be profitable?
Its figures don’t show a steady enough trend to project a date. In the 12 months to Dec 2025, revenue was $8.00K and expenses $33.2M.
| Fiscal year to | Revenue | Expenses | Operating profit |
|---|---|---|---|
| Dec 2025 | $8.00K | $33.2M | −$33.2M |
| Dec 2024 | $8.00K | $31.7M | −$31.7M |
| Dec 2023 | $170K | $24.3M | −$24.2M |
| Dec 2022 | $11.1M | $14.1M | −$3.01M |
When the cash runs out, on the chart. A red line at the date the company’s cash would run out at its latest burn, so you can see whether it gets to break-even first. Part of a subscription.